Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level

키워드

참고문헌 (15)

1. Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)
2. European Association for the Study of the Liver, "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)
3. Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
4. San Juan López Cristina, "Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases", Clinical and Molecular Hepatology, 24(4), pp.384~391 (2018), 대한간학회
5. Liguo Zhu, "Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study", Liver International, 39(1), pp.70~80 (2019), Wiley[DOI]
6. Wong VW, "Hepatitis B virus infection and fatty liver in the general population", J Hepatol, 56, pp.533~540 (2012)
7. Fan JG, "New trends on obesity and NAFLD in Asia", J Hepatol, 67, pp.862~873 (2017)
8. Wong GL, "Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B", Gut, 58, pp.111~117 (2009)
9. Mofrad P, "Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values", Hepatology, 37, pp.1286~1292 (2003)
10. Petta S, "The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease", Hepatology, 62, pp.1101~1110 (2015)
11. Friedrich-Rust M, "Performance of transient elastography for the staging of liver fibrosis : a meta-analysis", Gastroenterology, 134, pp.960~974 (2008)
12. Poynard T, "Meta-analyses of FibroTest diagnostic value in chronic liver disease", BMC Gastroenterol, 7, pp.40~ (2007)
13. Brunetto MR, "Outcome of anti-HBe positive chronic hepatitis B in alphainterferon treated and untreated patients : a long term cohort study", J Hepatol, 36, pp.263~270 (2002)
14. Kim GA, "High risk of hepatocellular carcinoma and death in patients with immunetolerant-phase chronic hepatitis B", Gut, 67, pp.945~952 (2018)
15. Jung KS, "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement(FibroScan)", Hepatology, 53, pp.885~894 (2011)

관련 논문AI추천